πŸ‡ΊπŸ‡Έ FDA
Patent

US 9346875

Therapy for filovirus infection

granted A61KA61K2039/505

Quick answer

US patent 9346875 (Therapy for filovirus infection) held by The United States of America as represented by the Secretary of the Army expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/505